Indivior Pharmaceuticals, Inc. (INDV) Q1 2024 Earnings
INDV·Reported April 25, 2024·Before market open
Indivior Pharmaceuticals, Inc. reported Q1 2024 revenue of $282.7M, missed analyst consensus of $299.8M by $17.0M. Diluted EPS came in at $0.37, missed the $0.42 consensus by $0.05.
Revenue
$282.7Mmissed by $17.0M
Consensus: $299.8MDiluted EPS
$0.37missed by $0.05
Consensus: $0.42
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q1 2024 Earnings FAQ
Common questions about Indivior Pharmaceuticals, Inc. 's Q1 2024 earnings report.
Indivior Pharmaceuticals, Inc. (INDV) reported Q1 2024 earnings on April 25, 2024 before market open.
Indivior Pharmaceuticals, Inc. reported revenue of $282.7M and diluted EPS of $0.37 for Q1 2024.
Revenue missed the consensus estimate of $299.8M by $17.0M. EPS missed the consensus estimate of $0.42 by $0.05.